Research teams in the UK and the US have also been investigating nasal spray vaccines. In November, India's drug regulator approved the use of iNCOVACC as a heterologous booster dose - a booster ...
In India too, ITC was reported developing a nasal spray to prevent infection and transmission of COVID-19. The nasal spray is designed to stop the virus at the entry point in the nasal cavity itself.
"The nasal vaccine provides a mucosal antigen boost ... the chief of the premier Delhi-based All India Institute of Medical Sciences (AIIMS) said. India’s coronavirus infections rose by another ...
Anish Sinha, Associate Professor at the Indian Institute of Public Health, said that intranasal vaccine can be a gamechanger, particularly in countries which have logistical issues. "The ease of ...